SBFM Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sunshine Biopharma Inc (SBFM).


$6.00M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

SBFM Market Cap. (MRY)


SBFM Shares Outstanding (MRY)


SBFM Assets (MRY)


Total Assets

$30.56M

Total Liabilities

$7.06M

Total Investments

$0

SBFM Income (MRY)


Revenue

$34.87M

Net Income

-$5.13M

Operating Expense

$16.48M

SBFM Cash Flow (MRY)


CF Operations

-$12.53M

CF Investing

-$2.32M

CF Financing

$9.29M

SBFM Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SBFM Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$30,560,392 (11.75%)

$27,346,961 (-6.49%)

$29,243,848 (1227.52%)

$2,202,891 (110.71%)

Assets Current

$25,966,349 (4.32%)

$24,890,055 (-8.87%)

$27,312,334 (1143.83%)

$2,195,830 (114.03%)

Assets Non-Current

$4,594,043 (86.98%)

$2,456,906 (27.20%)

$1,931,514 (27254.68%)

$7,061 (-63.85%)

Goodwill & Intangible Assets

$3,019,717 (109.08%)

$1,444,259 (85.91%)

$776,856 (0%)

$0 (0%)

Shareholders Equity

$23,500,754 (10.81%)

$21,207,361 (-1.94%)

$21,627,570 (10117.97%)

$211,662 (122.17%)

Property Plant & Equipment Net

$1,482,092 (46.36%)

$1,012,647 (-12.30%)

$1,154,658 (16252.61%)

$7,061 (-63.85%)

Cash & Equivalents

$9,686,529 (-40.55%)

$16,292,347 (-25.35%)

$21,826,437 (963.27%)

$2,052,757 (105.79%)

Accumulated Other Comprehensive Income

-$829,959 (-219.23%)

$696,105 (330.10%)

$161,847 (799.46%)

-$23,139 (-705.96%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$11,278,105 (96.66%)

$5,734,755 (74.31%)

$3,289,945 (3014.00%)

$105,650 (344.45%)

Trade & Non-Trade Receivables

$3,868,418 (51.56%)

$2,552,362 (33.48%)

$1,912,153 (24421.07%)

$7,798 (306.99%)

Trade & Non-Trade Payables

$5,838,882 (13.75%)

$5,133,297 (-20.23%)

$6,434,797 (14884.86%)

$42,942 (-31.70%)

Accumulated Retained Earnings (Deficit)

-$69,039,774 (-8.03%)

-$63,905,658 (-7.59%)

-$59,399,614 (-81.90%)

-$32,655,174 (-61.51%)

Tax Assets

$92,234 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$268,276 (-23.04%)

$348,598 (-16.25%)

$416,223 (0%)

$0 (0%)

Total Debt

$952,480 (44.82%)

$657,705 (-14.05%)

$765,258 (-59.72%)

$1,900,000 (-0.69%)

Debt Current

$207,756 (75.07%)

$118,670 (-3.54%)

$123,026 (0%)

$0 (0%)

Debt Non-Current

$744,724 (38.16%)

$539,035 (-16.07%)

$642,232 (-66.20%)

$1,900,000 (100.21%)

Total Liabilities

$7,059,638 (14.99%)

$6,139,600 (-19.39%)

$7,616,278 (282.49%)

$1,991,229 (-0.45%)

Liabilities Current

$6,314,914 (13.74%)

$5,551,836 (-19.90%)

$6,931,014 (7497.38%)

$91,229 (-91.32%)

Liabilities Non-Current

$744,724 (26.70%)

$587,764 (-14.23%)

$685,264 (-63.93%)

$1,900,000 (100.21%)

SBFM Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$34,874,283 (44.75%)

$24,092,787 (454.42%)

$4,345,603 (1802.41%)

$228,426 (219.88%)

Cost of Revenue

$24,204,489 (53.64%)

$15,753,616 (494.69%)

$2,649,028 (2148.18%)

$117,830 (355.87%)

Selling General & Administrative Expense

$14,937,481 (38.11%)

$10,815,648 (14.11%)

$9,478,352 (408.01%)

$1,865,780 (207.56%)

Research & Development Expense

$933,902 (-49.68%)

$1,855,830 (128.59%)

$811,858 (20.77%)

$672,209 (38800.98%)

Operating Expenses

$16,481,915 (25.58%)

$13,124,470 (-54.27%)

$28,697,325 (1025.06%)

$2,550,730 (309.80%)

Interest Expense

$8,774 (-93.61%)

$137,308 (248.39%)

$39,412 (-88.01%)

$328,818 (95.60%)

Income Tax Expense

-$234,858 (-159.43%)

$395,166 (69.38%)

$233,304 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,134,116 (-13.94%)

-$4,506,044 (83.15%)

-$26,744,440 (-115.05%)

-$12,436,447 (-346.70%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,134,116 (-13.94%)

-$4,506,044 (83.15%)

-$26,744,440 (-115.05%)

-$12,436,447 (-346.70%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,134,116 (-13.94%)

-$4,506,044 (83.15%)

-$26,744,440 (-115.05%)

-$12,436,447 (-346.70%)

Weighted Average Shares

$701,749 (-97.12%)

$24,331,908 (60.28%)

$15,180,868 (481.18%)

$2,612,061 (155.96%)

Weighted Average Shares Diluted

$701,749 (-97.12%)

$24,331,908 (60.28%)

$15,180,868 (481.18%)

$2,612,061 (155.96%)

Earning Before Interest & Taxes (EBIT)

-$5,360,200 (-34.90%)

-$3,973,570 (84.99%)

-$26,471,724 (-118.64%)

-$12,107,629 (-362.83%)

Gross Profit

$10,669,794 (27.95%)

$8,339,171 (391.53%)

$1,696,575 (1434.03%)

$110,596 (142.73%)

Operating Income

-$5,812,121 (-21.46%)

-$4,785,299 (82.28%)

-$27,000,750 (-1006.53%)

-$2,440,134 (-322.99%)

SBFM Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$2,320,847 (-253.71%)

-$656,150 (95.51%)

-$14,619,390 (0%)

$0 (0%)

Net Cash Flow from Financing

$9,289,507 (171.18%)

$3,425,587 (-91.32%)

$39,465,107 (1258.68%)

$2,904,675 (80.61%)

Net Cash Flow from Operations

-$12,531,180 (-42.80%)

-$8,775,111 (-67.20%)

-$5,248,358 (-186.93%)

-$1,829,128 (-178.28%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,562,520 (7.38%)

-$6,005,674 (-130.65%)

$19,597,359 (1722.08%)

$1,075,547 (13.24%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$14,347,772 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,998,589 (-4121.47%)

$49,698 (130.94%)

-$160,603 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$347,935 (376.16%)

-$125,990 (96.85%)

-$3,996,255 (-240.56%)

$2,843,175 (81.37%)

Issuance (Purchase) of Equity Shares

$5,382,760 (51.71%)

$3,548,075 (-88.32%)

$30,367,185 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$1,043,298 (-321.23%)

$471,584 (156.42%)

$183,911 (1007.40%)

-$20,268 (-5290.43%)

Share Based Compensation

$12,000 (0%)

$0 (0%)

$0 (0%)

$918,000 (1736.00%)

Depreciation Amortization & Accretion

$223,527 (49.87%)

$149,147 (492.72%)

$25,163 (97.50%)

$12,741 (-9.42%)

SBFM Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

30.60% (-11.56%)

34.60% (-11.28%)

39.00% (-19.42%)

48.40% (-24.14%)

Profit Margin

-14.70% (21.39%)

-18.70% (96.96%)

-615.40% (88.70%)

-5444.40% (-39.65%)

EBITDA Margin

-14.70% (7.55%)

-15.90% (97.39%)

-608.60% (88.51%)

-5294.90% (-45.32%)

Return on Average Equity (ROAE)

-21.20% (-0.95%)

-21.00% (77.00%)

-91.30% (-105.36%)

1704.00% (320.12%)

Return on Average Assets (ROAA)

-16.90% (-3.68%)

-16.30% (80.87%)

-85.20% (85.65%)

-593.60% (4.15%)

Return on Sales (ROS)

-15.40% (6.67%)

-16.50% (97.29%)

-609.20% (88.51%)

-5300.50% (-44.69%)

Return on Invested Capital (ROIC)

-52.90% (60.17%)

-132.80% (99.28%)

-18408.00% (-3331.77%)

-536.40% (41.64%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.41 (71.31%)

-1.43 (-292.58%)

-0.36 (85.18%)

-2.46 (-113.57%)

Price to Sales Ratio (P/S)

0.06 (-78.10%)

0.27 (-87.75%)

2.24 (-98.33%)

133.68 (197.91%)

Price to Book Ratio (P/B)

0.26 (-22.49%)

0.33 (-50.75%)

0.67 (-99.53%)

142.31 (2703.57%)

Debt to Equity Ratio (D/E)

0.3 (3.45%)

0.29 (-17.61%)

0.35 (-96.26%)

9.41 (549.07%)

Earnings Per Share (EPS)

-7.32 (-3752.63%)

-0.19 (89.20%)

-1.76 (63.03%)

-4.76 (-74.36%)

Sales Per Share (SPS)

49.7 (4919.80%)

0.99 (246.15%)

0.29 (228.74%)

0.09 (24.29%)

Free Cash Flow Per Share (FCFPS)

-20.7 (-5667.41%)

-0.36 (-0.84%)

-0.36 (49.14%)

-0.7 (-8.53%)

Book Value Per Share (BVPS)

33.49 (3740.48%)

0.87 (-38.81%)

1.43 (1659.26%)

0.08 (108.65%)

Tangible Assets Book Value Per Share (TABVPS)

39.25 (3585.07%)

1.06 (-43.20%)

1.88 (122.42%)

0.84 (-17.68%)

Enterprise Value Over EBIT (EV/EBIT)

1 (-66.67%)

3 (200.00%)

1 (133.33%)

-3 (-50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

1.1 (-62.44%)

2.93 (196.76%)

0.99 (138.18%)

-2.58 (-17.18%)

Asset Turnover

1.15 (31.16%)

0.87 (532.61%)

0.14 (26.61%)

0.11 (-31.45%)

Current Ratio

4.11 (-8.28%)

4.48 (13.75%)

3.94 (-83.63%)

24.07 (2366.09%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$14,529,769 (-66.52%)

-$8,725,413 (-61.31%)

-$5,408,961 (-195.71%)

-$1,829,128 (-177.78%)

Enterprise Value (EV)

-$5,651,124 (49.55%)

-$11,200,957 (57.10%)

-$26,108,717 (-183.52%)

$31,261,831 (444.75%)

Earnings Before Tax (EBT)

-$5,368,974 (-30.60%)

-$4,110,878 (84.49%)

-$26,511,136 (-113.17%)

-$12,436,447 (-346.70%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,136,673 (-34.31%)

-$3,824,423 (85.54%)

-$26,446,561 (-118.66%)

-$12,094,888 (-364.84%)

Invested Capital

$12,491,712 (164.87%)

$4,716,224 (893.31%)

$474,799 (-75.76%)

$1,958,905 (115.31%)

Working Capital

$19,651,435 (1.62%)

$19,338,219 (-5.12%)

$20,381,320 (868.42%)

$2,104,601 (8398.25%)

Tangible Asset Value

$27,540,675 (6.32%)

$25,902,702 (-9.01%)

$28,466,992 (1192.26%)

$2,202,891 (110.71%)

Market Capitalization

$5,998,980 (-13.95%)

$6,971,656 (-51.77%)

$14,454,804 (-52.01%)

$30,121,814 (477.16%)

Average Equity

$24,212,386 (13.00%)

$21,427,529 (-26.88%)

$29,303,023 (4114.98%)

-$729,842 (-6.33%)

Average Assets

$30,454,226 (10.34%)

$27,599,654 (-12.04%)

$31,377,124 (1397.65%)

$2,095,086 (366.04%)

Invested Capital Average

$10,132,279 (238.51%)

$2,993,211 (1981.44%)

$143,805 (-93.63%)

$2,257,040 (692.99%)

Shares

1,999,660 (-92.21%)

25,678,290 (13.69%)

22,585,632 (776.53%)

2,576,716 (55.03%)